Clinical Trials in Brazil / NCT05862779
Active, not recruiting Not applicable

Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults

NCT05862779 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2024-07-30
Last updated
2026-09-24

Condition(s) studied

Sarcopenia

Investigational drug(s) / intervention(s)

Placebo GroupWhey Protein + PlaceboOmega 3 + PlaceboOmega 3 + Whey Protein

Placebo Group: The placebo group will receive 5 g per day of sunflower oil and 38 g per day of maltodextrin.

Whey Protein + Placebo: The whey protein + placebo group will receive 38g per day of whey and 5g per day of sunflower oil.

Omega 3 + Placebo: The omega 3 + placebo group will receive 5 g per day of fish oil and 38 g per day of maltodextrin.

Omega 3 + Whey Protein: The omega 3 + whey group will receive 5g per day of fish oil and 38g per day of protein.

Study summary

To evaluate the effect of omega-3 supplementation combined with whey protein intake on lean mass, muscle strength, metabolomic and lipidomic profiles, and biomarkers of oxidative stress and inflammation in older adults undergoing resistance exercise. Participants will be randomized into the 4 groups. The placebo group will receive 5 g per day of sunflower oil and 38 g per day of maltodextrin. The omega 3 + placebo group will receive 5 g per day of fish oil and 38 g per day of maltodextrin. The whey protein + placebo group will receive 38g per day of whey and 5g per day of sunflower oil. The omega 3 + whey group will receive 5g per day of fish oil and 38g per day of protein. All will perform the same exercise protocol for 12 weeks.

Eligibility

Sex
FEMALE
Min age
60 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Postmenopausal women (at least 1 year of menstrual interruption, self-reported); * To be able to practice strength exercises; * To be able to carry out supplementation; * Do not present physical, orthopedic or cardiovascular complications that prevent the performance of physical exercises; * No history of stroke or acute myocardial infarction; * Not being a smoker and/or alcoholic; * Do not perform hormone replacement therapy; * Do not use anti-inflammatory drugs; * To have normal kidney function; * To submit a medical certificate of health that proves that the individual is able to perform exercises. Exclusion Criteria: * Do not provide the necessary information for the development of the study; * Individuals with diseases previously diagnosed and undergoing treatment, such as type II diabetes mellitus, cancer, rheumatoid arthritis, cardiovascular, and kidney and/or liver diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Federal University of Uberlandia Uberlândia Minas Gerais

More Federal University of Uberlandia trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05862779 on ClinicalTrials.gov ↗ ← All trials in Brazil